An initiative involving companies and institutes in 15 middle-income countries aims to give them the ability to produce messenger RNA vaccines.
As pandemic raged, global south lacked vaccines. Never again, researchers vow.
An initiative involving companies and institutes in 15 middle-income countries aims to give them the ability to produce messenger RNA vaccines.